Mesa Laboratories
MLAB
Mesa Laboratories (MLAB) earnings history
Most recent quarter
- Fiscal period
- Q1 2027
- Period end
- Jun 30, 2026
- EPS actual
- $2.68
- EPS estimate
- $2.63
- EPS surprise
- +2.10%
- Revenue surprise
- −1.20%
- Revenue
- $60.1M
- Revenue estimate
- $60.9M
- Reported
- Aug 10, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2027 | Aug 10, 2026 | $2.63 | $2.68 | +2.10% | $60.1M | SEC |
| Q4 2026 | May 27, 2026 | $2.09 | $3.30 | +58.27% | $63.7M | SEC |
| Q3 2026 | Feb 3, 2026 | $1.40 | $3.07 | +119.29% | $65.1M | SEC |
| Q2 2026 | Nov 6, 2025 | $1.62 | $2.75 | +70.10% | $60.7M | SEC |
| Q1 2026 | Aug 5, 2025 | $2.27 | $2.32 | +2.20% | $59.5M | SEC |
| Q4 2025 | May 28, 2025 | $2.29 | $2.25 | −1.89% | $62.1M | SEC |
| Q3 2025 | Feb 4, 2025 | $1.72 | $2.72 | +58.06% | $62.8M | SEC |
| Q2 2025 | Nov 7, 2024 | $1.89 | $2.62 | +38.62% | $57.8M | SEC |
| Q1 2025 | Aug 5, 2024 | $1.77 | $2.83 | +59.89% | $58.2M | SEC |
| Q4 2024 | Jun 5, 2024 | $1.91 | $2.77 | +45.28% | $58.9M | SEC |
| Q3 2024 | Feb 5, 2024 | $1.79 | $2.02 | +13.06% | $53.5M | SEC |
| Q2 2024 | Nov 6, 2023 | $1.79 | $1.91 | +6.90% | $53.2M | SEC |
| Q1 2024 | Aug 3, 2023 | $0.86 | $1.77 | +105.81% | $50.6M | SEC |
| Q4 2023 | May 25, 2023 | $1.69 | $1.94 | +15.07% | $55.6M | SEC |
| Q3 2023 | Feb 6, 2023 | $1.59 | $1.80 | +13.38% | $54.3M | SEC |
| Q2 2023 | Nov 3, 2022 | $1.21 | $2.88 | +137.37% | $58.7M | — |
| Q1 2023 | Aug 4, 2022 | $1.48 | $1.17 | −20.68% | $50.5M | — |
| Q4 2022 | May 31, 2022 | $1.80 | $2.22 | +23.44% | $58.9M | — |
| Q3 2022 | Feb 3, 2022 | $1.29 | $1.36 | +5.70% | $54.7M | — |
| Q2 2022 | Nov 4, 2021 | $1.07 | $1.87 | +75.59% | $35.8M | — |
Quarterly revenue
Frequently asked questions
When did Mesa Laboratories (MLAB) last report earnings?
Mesa Laboratories last reported on Aug 10, 2026, covering fiscal Q1 2027.
Did MLAB beat earnings estimates?
Yes. Mesa Laboratories reported EPS of $2.68 for Q1 2027 against a $2.63 estimate — a 2.10% beat.
How much revenue did MLAB report last quarter?
Mesa Laboratories reported $60.1M in revenue for Q1 2027, against a consensus estimate of $60.9M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.